You have accessJournal of UrologyProstate Cancer: Localized (I)1 Apr 2013360 SAFE-R: A NOVEL SCORE, ACCOUNTING FOR ONCOLOGICAL SAFE NERVE-SPARING Andreas Becker, Meike Adam, Jens Hansen, Pierre Tennstedt, Thomas Steuber, Georg Salomon, Alexander Haese, Lars Budaeus, Uwe Michl, Hans Heinzer, Hartwig Huland, Markus Graefen, and Thorsten Schlomm Andreas BeckerAndreas Becker Hamburg, Germany More articles by this author , Meike AdamMeike Adam Hamburg, Germany More articles by this author , Jens HansenJens Hansen Hamburg, Germany More articles by this author , Pierre TennstedtPierre Tennstedt Hamburg, Germany More articles by this author , Thomas SteuberThomas Steuber Hamburg, Germany More articles by this author , Georg SalomonGeorg Salomon Hamburg, Germany More articles by this author , Alexander HaeseAlexander Haese Hamburg, Germany More articles by this author , Lars BudaeusLars Budaeus Hamburg, Germany More articles by this author , Uwe MichlUwe Michl Hamburg, Germany More articles by this author , Hans HeinzerHans Heinzer Hamburg, Germany More articles by this author , Hartwig HulandHartwig Huland Hamburg, Germany More articles by this author , Markus GraefenMarkus Graefen Hamburg, Germany More articles by this author , and Thorsten SchlommThorsten Schlomm Hamburg, Germany More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2013.02.1747AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Risk-stratification based on preoperative data cannot reliably predict organ-confined disease. This is of particular relevance for selecting patients for nerve-sparing (NS) radical prostatectomy (RP). We assessed the impact of our intraoperative neurovascular structure adjacent frozen section examination (NeuroSAFE) guided nerve-sparing approach on the frequency of nerve-sparing and surgical margin rates in D'Amico low-, intermediate-, and high-risk patients, applying a novel score (SAFE-R), combining surgical margin status (SM) and extend of NS. METHODS From January 2002 to January 2011, 9,674 consecutive RPs were performed at our center. Of these, 4,518 (47%) were conducted with NeuroSAFE. Proportions of NS, SM-status were assessed. Subsequently, a score for oncological safe NS (SAFE-R) was developed. SAFE-R was categorized as 3 (for negative SM and bilateral NS), 2 (for negative SM and unilateral NS), 1 (for negative SM without NS) and 0 (for patients with positive SM), respectively. The impact of NeuroSAFE on SAFE-R was analyzed by chi-square test and confirmed with a multinominal logistic regression, controlling for preoperative risk-factors. All analyses were stratified for patients of low- intermediate- or high-risk according to the D'Amico classification. RESULTS D'Amico high-, intermediate- and low-risk profile was found in 1,319 (13.6%), 4,245 (43.9%) and 4,110 (42.5%) of all patients respectively. Within the low-risk group, a SAFE-R-0 (positive SM) was significantly less prevalent and SAFE-R scores of 2 or 3 (uni- or bilateral NS and negative SM) were more prevalent in patients undergoing neuroSAFE, compared to non-neuroSAFE patients (10.5 vs. 13.2%, and 88.1 vs. 85.7%, respectively, p<0.001). Similarly, in intermediate and high-risk patients, neuroSAFE resulted in lower proportions of SAFE-R score 0 (15.9 vs. 19.9% and 27.6 vs. 33.6%) and higher proportions of SAFE-R score 3 (53.7 vs. 44.1% and 32.4 vs. 17.3%, respectively, all p<0.001). Linkage between the neuroSAFE approach and SAFE-R was confirmed after multinominal logistic adjustment for preoperative risk factors. CONCLUSIONS SAFE-R represents a novel score to assess and report on oncological safe nerve-sparing in RP. Frozen section navigated nerve-sparing (NeuroSAFE) is associated with enhanced SAFE-R-scores without compromising oncological safety, even in high-risk patients. © 2013 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 189Issue 4SApril 2013Page: e146 Advertisement Copyright & Permissions© 2013 by American Urological Association Education and Research, Inc.MetricsAuthor Information Andreas Becker Hamburg, Germany More articles by this author Meike Adam Hamburg, Germany More articles by this author Jens Hansen Hamburg, Germany More articles by this author Pierre Tennstedt Hamburg, Germany More articles by this author Thomas Steuber Hamburg, Germany More articles by this author Georg Salomon Hamburg, Germany More articles by this author Alexander Haese Hamburg, Germany More articles by this author Lars Budaeus Hamburg, Germany More articles by this author Uwe Michl Hamburg, Germany More articles by this author Hans Heinzer Hamburg, Germany More articles by this author Hartwig Huland Hamburg, Germany More articles by this author Markus Graefen Hamburg, Germany More articles by this author Thorsten Schlomm Hamburg, Germany More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
Read full abstract